Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report.
Mego
M
M
Sycova-Mila
Z
Z
Rejlekova
K
K
Rychly
B
B
Obertova
J
J
Rajec
J
J
Hes
O
O
Mardiak
J
J
D000328:Adult; D001707:Biopsy, Needle; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D007685:Kidney Tubules, Collecting / Q000473:pathology*; D008297:Male; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000379:methods; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib